Results

Total Results: 159 records

Showing results for "bone".
Users also searched for: bone density

61. Final Research Plan: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/oral-health-children-adolescents-screening-preventive-interventions
    June 17, 2021 - of life Functional status Harms of screening and treatment (e.g., dental fluorosis, tooth staining, bone

62. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
    September 01, 2019 - In addition, some of these medicines may also lower the chance of breaking a bone, such as the spine

63. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
    September 01, 2019 - In addition, some of these medicines may also lower the chance of breaking a bone, such as the spine

64. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
    April 01, 2013 - J Bone Miner Res. 2004;19: 1270-5. [PMID: 15231013] 34. … J Bone Miner Res. 2005;20:1514-24. [PMID: 16059623] 47. … Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early … J Bone Miner Res. 1998;13:1747-54. [PMID: 9797484] 58. … Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal

65. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Bone . 2003;33(4):522-532. 68. … J Bone Miner Res . 2004;19(8):1270-1275. 70. … J Bone Miner Res . 2005;20(9):1514-1524. 75. Lippman ME, Cummings SR, Disch DP, et al. … J Bone Miner Res. 2008;23(1):112-120. 78. … in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.

66. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Bone . 2003;33(4):522-532. 68. … J Bone Miner Res . 2004;19(8):1270-1275. 70. … J Bone Miner Res . 2005;20(9):1514-1524. 75. Lippman ME, Cummings SR, Disch DP, et al. … J Bone Miner Res. 2008;23(1):112-120. 78. … in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.

67. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - Bone. 2003;33(4):522-532. doi:10.1016/S8756-3282(03) 00241-2 68. … J Bone Miner Res. 2004;19(8): 1270-1275. doi:10.1359/JBMR.040406 70. … J Bone Miner Res. 2005;20(9):1514- 1524. doi:10.1359/JBMR.050509 75. … J Bone Miner Res. 2008;23(1):112-120. doi:10.1359/jbmr.070904 78. … in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial [

68. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - associated with significant adverse events in adolescents but may be associated with slightly less bone … differences between PrEP and placebo. 44 , 46-50 Tenofovir disoproxil fumarate exposure is associated with bone … Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized … Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind … Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure

69. Screening for Syphilis Infection During Pregnancy: USPSTF Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/YJtsbuhNtrLyn6NpJZtfXk
    April 24, 2023 - birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones … weight, stillbirth, neonatal death, and sig- nificant abnormalities in the infant such as deformed bones … birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones

70. Chemo and Couns/2nd instal (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
    July 01, 2002 - Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Bone mass and breast cancer risk in older women: differences by stage at diagnosis. … Bone mass and the risk of breast cancer among postmenopausal women. … than breast cancer, women with particularly increased (or decreased) risk of thromboembolic events, bone … Possible benefits from tamoxifen or raloxifene chemoprevention include reduced risk of heart disease and bone

71. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Bone mass and breast cancer risk in older women: differences by stage at diagnosis. … Bone mass and the risk of breast cancer among postmenopausal women. … than breast cancer, women with particularly increased (or decreased) risk of thromboembolic events, bone … Possible benefits from tamoxifen or raloxifene chemoprevention include reduced risk of heart disease and bone

72. Evidence Gaps Research Taxonomy Table: Research Gaps for Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xBhJwGtUHqmEvPg_gKk4nw
    January 01, 2001 - , quality of life, functional status, or morbidity KQ 5: Dental fluorosis, tooth staining, bone

73. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
    June 11, 2019 - associated with significant adverse events in adolescents but may be associated with slightly less bone … ferences between PrEP and placebo.44,46-50 Tenofovir disoproxil fumarate exposure is associated with bone … Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized … Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind … Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure

74. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KFZpoMBYuoo8TRW6nhRev8
    October 23, 2023 - intracellular drug levels at lower tenofovir se- rum levels, potentially increasing effectiveness and bone … 2694) vs 17% (453/2693) Nausea: 4.2% (114/2694) vs 4.6% (123/2693) in primary (interim) analysis Hip bone … +0.6% vs –1.0% in persons aged ≥25 y (P < .001) and +1.2% vs –1.7% in persons <25 y (P = .04) Spine bone … associated with increased efficacy.42,54 TAF/FTC was associated with positive short- term effects on bone … between newer vs older PrEP regimens in inter- mediate outcomes (weight gain, lipid parameters, or bone

75. Evidence Gaps Research Taxonomy Table: Screening for Osteoporosis to Prevent Fractures (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/kHT3WGUaG2wTz2pF_ke7bn
    Abbreviations: BMD=bone mineral density; DXA=dual-energy X-ray absorptiometry; FDA=U.S.

76. Final Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
    March 31, 2016 - medical treatment, inducement of eating disorder, nausea or other gastrointestinal effects, reduced bone

77. Archived: Syphilis Infection in Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
    May 15, 2009 - Importance Untreated syphilis during pregnancy is associated with stillbirth, neonatal death, bone

78. Recommendation: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening
    May 13, 2025 - birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones … birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones

79. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
    December 15, 2020 - vs nonpreferred therapy. 38 , 41 No trial compared preferred vs nonpreferred antiviral therapy for bone … Data on risks of kidney and bone adverse events were limited but did not indicate increased risk; this … included the antiviral TDF, which has been associated with bone and kidney toxicities in some conditions … antiviral TAF, which was FDA-approved for chronic HBV infection in 2016 and may have fewer kidney and bone

80. Archived: Evidence Summary: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/falls-prevention-in-older-adults-interventions-2018
    April 17, 2018 - Effects on balance, falls, and bone mineral density of a home-based exercise program without home visits … Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. … J Bone Miner Res . 2012;27(1):170-176. 66. Sanders KM, Stuart AL, Williamson EJ, et al. … Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older